McNinch A W, Upton C, Samuels M, Shearer M J, McCarthy P, Tripp J H, L'E Orme R
Arch Dis Child. 1985 Sep;60(9):814-8. doi: 10.1136/adc.60.9.814.
One hundred and seven healthy, breast fed infants received 1 mg vitamin K1 either at birth (orally or intramuscularly) or with the first feed (orally). Venous blood samples collected in the next 24 hours were assayed for plasma vitamin K1. In babies given the vitamin orally at birth, the peak median concentration (73 ng/ml) occurred at four hours. By 24 hours median plasma concentrations had fallen to 23 ng/ml and 35 ng/ml in the groups fed vitamin K1 at birth or with the first feed, respectively; this difference was not, however, significant. Plasma concentrations after intramuscular injection exceeded those in the oral groups at all comparable times, with a peak median concentration of 1781 ng/ml at 12 hours falling to 444 ng/ml at 24 hours. Since median plasma vitamin K1 concentrations 24 hours after oral administration were some 100 times and 1000 times greater than previously estimated adult and newborn values respectively, this study supports giving vitamin K1 orally at birth to well, mature babies to protect against early haemorrhagic disease of the newborn. Further studies are needed to determine the optimum dose for protection over subsequent weeks.
107名健康的母乳喂养婴儿在出生时(口服或肌肉注射)或首次喂奶时(口服)接受了1毫克维生素K1。在接下来的24小时内采集静脉血样,检测血浆维生素K1。在出生时口服维生素的婴儿中,峰值中位浓度(73纳克/毫升)出现在4小时。到24小时时,出生时或首次喂奶时服用维生素K1的组中,血浆中位浓度分别降至23纳克/毫升和35纳克/毫升;然而,这种差异并不显著。肌肉注射后的血浆浓度在所有可比时间都超过口服组,峰值中位浓度在12小时时为1781纳克/毫升,在24小时时降至444纳克/毫升。由于口服给药后24小时的血浆维生素K1中位浓度分别比先前估计的成人和新生儿值高约100倍和1000倍,本研究支持对健康、成熟的婴儿在出生时口服维生素K1,以预防早期新生儿出血性疾病。需要进一步研究以确定在随后几周提供保护的最佳剂量。